Calcitonin Metabolism in Senile (Type II) Osteoporosis

[en] The exact role of calcitonin (CT) in the pathogenesis of senile (Type II) osteoporosis remains unknown. Whole plasma calcitonin (iCT) and extracted monomeric calcitonin (eCT) basal levels, metabolic clearance rate (MCR) and production rate (PR) of iCT and eCT were measured in 41 postmenopausal women, including 14 hip fractures (OP II) and 27 healthy controls. No significant difference appeared for basal iCT levels between OP II (mean +/- SEM: 41.9 +/- 3.4 pg/ml) and controls (mean +/- SEM: 46.2 +/- 5 pg/ml). eCT basal levels were similar in OP II (mean +/- SEM: 5.42 +/- 0.5 pg/ml) and in controls (mean +/- SEM: 7.3 +/- 0.7 pg/ml). MCR were similar in the two groups. iCT PR were similar in OP II (mean +/- SEM: 17.2 +/- 1.5 micrograms/24 h) and controls (mean +/- SEM: 18.6 +/- 1.1 micrograms/24 h). No difference appeared between eCT PR in OP II (mean +/- SEM: 2.3 +/- 0.2 micrograms/24 h) and controls (mean +/- SEM: 3.2 +/- 0.3 pg/ml). From these data, no evidence appears that calcitonin might be one of the determinant factors in the pathogenesis of senile osteoporosis.

Disciplines :

Rheumatology

Author, co-author :

Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique

Deroisy, Rita ; Centre Hospitalier Universitaire de Liège - CHU > Médecine de l'appareil locomoteur

Bruwier, Maurice ; Université de Liège - ULiège > Département des sciences de la santé publique > Ecole de santé publique

Franchimont, P.

Language :

English

Title :

Calcitonin Metabolism in Senile (Type II) Osteoporosis

Publication date :

May 1992

Journal title :

Osteoporosis International

ISSN :

0937-941X

eISSN :

1433-2965

Publisher :

Springer, Germany

Volume :

Pages :

141-5

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 02 May 2012

Statistics

Number of views

49 (3 by ULiège)

Number of downloads

1 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Parfitt A.M. (1979) Quantum concept of bone remodeling and turnover:implications for the pathogenesis of osteoporosis. Calcif Tissue Int 28:1-5.
Riggs B.L., Melton L.J. (1983) Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 75:899-901.
Riggs B.L., Melton L.J. (1986) Involutional osteoporosis. N Engl J Med 314:1676-86.
Lips P., Courpron P., Meunier P. (1978) Mean wall thickness of trabecular bone packets in human iliac crest:changes with age. Calcif Tissue Int 26:13-17.
Gallagher J.C., Riggs B.L., Eisman J., Hatra A., Arnaud S.B., De Luca H.F. (1979) Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest 64:729-36.
Friedman J., Raisz L.G. (1965) Thyrocalcitonin, inhibitor of bone resorption in tissue culture. Science 150:1465-7.
O'Riodan J.L., Aurbach G.D. (1966) Mode of action of thyrocalcitonin. Endocrinology 82:377-83.
Bijvoet O.L.M., Van Der Sluys Veer J., Jensen A.P. (1968) Effects of calcitonin on patients with Paget's disease, thyrotoxicosis and hypercalcaemia. Lancet 1:876-81.
Civitelli R., Gonneli S., Zacchei F. (1988) Bone turnover in postmenopausal osteoporosis; effect of calcitonin treatment. J Clin Invest 82:1268-74.
Reginster J.Y., Denis D., Albert A. (1987) 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 2:1481-3.
Tiegs R.D., Body J.J., Wahner H.W., Barta J., Riggs B.L., Heath H. (1985) Calcitonin secretion in postmenopausal osteoporosis. N Engl J Med 312:1097-100.
Leggate J., Farish E., Fletcher C.D., McIntosh W., Hart D.M., Sommerville J.M. (1984) Calcitonin and postmenopausal osteoporosis. Clin Endocrinol 20:85-92.
Hurley D.L., Tiegs R.D., Barta J., Lakkso K., Heath H. (1989) Effects of oral contraceptive and estrogen administration on plasma calcitonin in pre- and postmenopausal women. J Bone Miner Res 4:89-95.
Chesnut C., Baylink D.J., Sisom K., Nelp W.B., Roos B.A. (1980) Basal plasma immunoreactive calcitonin in postmenopausal osteoporosis. Metabolism 29:559-62.
Prince R., Dick I.M., Price R.I. (1989) Plasma calcitonin levels are not lower than normal in osteoporotic women. J Clin Endocrinol Metab 68:684-7.
Body J.J., Struelens M., Borkowski A. (1989) Effects of estrogens and calcium on calcitonin secretion in postmenopausal women. J Clin Endocrinol Metab 68:223-6.
Lobo R.A., Roy S., Shoupe D. (1985) Estrogen and progestin effects on urinary calcium and calciotropic hormones in surgical induced postmenopausal women. Horm Metab Res 17:370-3.
Selby P.L., Peacock M., Barkworth S.A., Brown W.B., Taylor G.A. (1985) Early effects of ethinyloestradiol and norethisterone treatment in postmenopausal women on bone resorption and calcium regulating hormones. Clin Sci 69:265-71.
Reginster J.Y., Deroisy R., Albert A. (1989) Relationship between whole plasma calcitonin levels, and estrone in healthy women and postmenopausal osteoporotics. J Clin Invest 83:1073-7.
Taggart, Ivey J.L., Sisom K., Chesnutt C.H., Baylink D.J., Huber M.B. (1982) Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis?. Lancet 1:475-8.
Stevenson J.C. (1982) Regulation of calcitonin and parathyroid hormone secretion by estrogens. Maturitas 4:1-7.
Galan Galan F., Perez Cano R., Rodrigez R. (1985) Deficit de calcitonina en la osteoporosis postmenopausica. Med Clin 85:221-2.
Hillyard C.J., Stevenson J.C., MacIntyre I. (1978) Relative deficiency of plasma calcitonin in normal women. Lancet 1:961-2.
Morimoto S., Tsuji M., Okada Y., Onishi T., Kumahara Y. (1980) The effect of estrogens on human calcitonin secretion after calcium infusion in elderly female subjects. Clin Endocrinol 13:135-43.
Milhaud G., Bezenech-Lefevre M., Moukhtar (1978) Deficiency of calcitonin in age-related osteoporosis. Biomedicine 29:272-6.
Stevenson J.C., Abeyasekera G., Hillyard C.J., Phang K.G., MacIntyre I. (1981) Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of estrogens. Lancet 1:693-5.
Stevenson J.C., Abeyasekera G., Hillyard C.J. (1983) Regulation of calcium-regulating hormones by exogenous sex steroids in early postmenopause. Eur J Clin Invest 13:481-7.
Zseli J., Szücs J., Steczek K. (1985) Decreased calcitonin reserve in accelerated postmenopausal osteoporosis. Horm Metab Res 17:696-7.
Perez Cano R., Montoya M.J., Moruno R., Vazquez A., Galan F., Garrido M. (1989) Calcitonin reserve in healthy women and patients with postmenopausal osteoporosis. Calcif Tissue Int 45:203-8.
Heynen G., Franchimont P. (1974) Human calcitonin radioimmunoassay in normal and pathological conditions. Eur J Clin Invest 4:213-22.
Body J.J., Heath H. (1984) ‘Non-specific’ increases in plasma immunoreactive calcitonin in healthy individuals: discrimination from medullary thyroid carcinoma by a new extraction technique. Clin Chem 30:511-14.
Beringer, Ardhill J., Taggart H.M. (1986) Absence of evidence for a role of calcitonin in the etiology of femoral neck fractures. Calcif Tissue Int 39:300-3.
Stevenson J.C., Allen P.R., Abeyasekera G., Hill P.A. (1986) Osteoporosis with hip fracture: changes in calcium-regulating hormones. Eur J Clin Invest 16:357-60.
Kanis J.A., Heynen G., Cundy T., Cornet F., Paterson A., Russel R.G.G. (1982) An estimate of the endogenous secretion rate of calcitonin in man. Clin Sci 63:145-52.
Tait J.F. (1978) Review: the use of isotopic steroids for the measurement of production rates in vivo. Anal Biochem 90:1-12.
Deftos L.J., Roos B.A., Bronzert D., Parthemore J.G. (1975) Immuno-chemical heterogeneity of calcitonin in plasma. J Clin Endocrinol Metab 40:409-12.
Singer F.R., Habener J.F. (1974) Multiple immunoreactive forms of calcitonin in human plasma. Biochem Biophys Res Commun 61:710-16.
Heynen G., Hendrick J.C., Franchimont P. (1976) Heterogeneity of calcitonin in human serum. Vitamin D and problems related to uraemic bone disease , A.W., Norman, K., Schaeffer, H.G., Grigoleit, D.V., Herrath, E., Ritz, E de Gruyter Publ, Berlin; 475-81.
Tiegs R.D., Body J.J., Barta J.M., Heath H. (1986) Secretion and metabolism of monomeric human calcitonin: effects of age, sex and thyroid damage. J Bone Miner Res 1:339-49.
Deftos L.J., Weisman M.H., Willia G.W. (1980) Influence of age and sex on plasma calcitonin in human beings. N Engl J Med 302:1351-3.
Lore F., Galli M., Franci B., Martorelli M.T. (1984) Calcitonin levels in normal subjects according to age and sex. Biomed Pharmacother 38:261-3.
Pedrazzoni M., Mantovani M., Ciotti G. (1988) Calcitonin levels in normal women of various age evaluated with a new sensitive radioimmunoassay. Horm Metab Res 20:118-19.
Heynen G., Franchimont P. (1974) Human calcitonin radioimmunoassay in normal and pathological conditions. Eur J Clin Invest 4:213-22.
Heath H., Sizemore G.W. (1977) Plasma calcitonin in normal man: differences between men and women. J Clin Invest 60:1135-40.
Body J.J., Heath H. (1983) Estimates of circulating monomeric calcitonin physiological studies in normal and thyroidectomized men. J Clin Endocrinol Metab 57:897-903.